INBIOGEN Co., Ltd. (KRX:101140)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,640
+170 (1.36%)
At close: Sep 4, 2025

INBIOGEN Revenue

INBIOGEN had revenue of 1.85B KRW in the quarter ending June 30, 2025, with 29.90% growth. This brings the company's revenue in the last twelve months to 7.74B, up 41.13% year-over-year. In the year 2024, INBIOGEN had annual revenue of 7.04B with 12.82% growth.

Revenue (ttm)
7.74B
Revenue Growth
+41.13%
P/S Ratio
16.18
Revenue / Employee
188.72M
Employees
41
Market Cap
125.21B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20247.04B800.26M12.82%
Dec 31, 20236.24B-4.18B-40.10%
Dec 31, 202210.42B-61.30M-0.58%
Dec 31, 202110.48B263.11M2.58%
Dec 31, 202010.22B422.51M4.31%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Hyundai Motor Company182.25T
Kia Corporation111.04T
Hyundai Mobis Co.,Ltd59.40T
Hanjin Kal285.51B
COWAY4,659.84B
Hankook Tire & Technology15.30T
Kangwon Land1,447.67B
F&F Co., Ltd1,881.99B
Revenue Rankings